Companies: 10,795·Total market cap: $144.5T
Applied Therapeutics, Inc.

Applied Therapeutics, Inc.

APLTNASDAQHealthcare
$0.10
+$0.00(+0.00%)
Market Cap$14862969
P/E Ratio
52W High$1.5
52W Low$0.09
Overview

Applied Therapeutics, Inc. (APLT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · APLT · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.11aplt eps ttm · aplt earnings per shareEarnings history
PE Ratio (TTM)aplt pe ratio ttm · aplt price to earningsPE Ratio deep dive
Revenue (TTM)$1.0Maplt revenue ttm · aplt annual revenueFull revenue history
Dividend YieldNo Dividenddoes aplt pay dividends · aplt dividend yieldDividend history
Shares Outstanding139.5Maplt shares outstanding · aplt floatShares outstanding history
Next EarningsTBAaplt earnings date · aplt next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$455000.00▼ 95.45% YoY
202220232024
applied therapeutics, inc. revenue · aplt revenue 2024
FY 2024Net Income-$105.6M▲ +11.81% YoY
202220232024
applied therapeutics, inc. net income · aplt profit 2024
FY 2024EPS$-0.76▲ +46.48% YoY
202220232024
aplt eps · applied therapeutics, inc. earnings per share 2024
TTM:Revenue: $1.0MNet Income: -$18.1MEPS: $-0.11View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy11 analystsis aplt a buy · aplt analyst rating
Strong Buy
0
Buy
5
Hold
5
Sell
1
Strong Sell
0
12-Month Price Target
$0.25Low
$0.10Current
$0.25Avg Target142.72% upside
$0.25High
aplt price target · aplt 12 month forecast

Total: 11 · Buy rate: 45.5%

The APLT analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $0.25, representing +142.72% upside from the current price of $0.10.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M-52.45%
YTD+0.29%
1Y-79.46%
5Y-99.38%

About Applied Therapeutics, Inc.

CEOLes D. Funtleyder
IPO DateMay 14, 2019
Employees35
CountryUS

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for cardiovascular conditions, galactosemia, and various diabetes-related complicati…

what is applied therapeutics, inc. · aplt stock overview · applied therapeutics, inc. company profile · who is applied therapeutics, inc. ceo · aplt NASDAQ · applied therapeutics, inc. headquarters · applied therapeutics, inc. business segments

About Stock Overview & Key Data

Applied Therapeutics, Inc. (APLT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 14, 2019. As of the latest trading session, APLT stock price is $0.10, with a market capitalization of $14.9M. The stock has returned -79.46% over the past 12 months and +0.29% year-to-date.

According to 11 Wall Street analysts, the consensus rating for Applied Therapeutics, Inc. stock is Buy, with an average 12-month price target of $0.25. In fiscal year 2024, Applied Therapeutics, Inc. reported revenue of $455000.00 and net income of -$105.6M. For detailed data — including Applied Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Applied Therapeutics, Inc. (APLT) stock price is $0.10. The stock is traded on NASDAQ under the ticker symbol APLT. The 52-week range is $0.09 – $1.50.

APLT stock priceAPLT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice